Melhus H, Michaelsson K, Kindmark A, et al. Excessive dietary intake of vitamin A is associated with reduced bone mineral density and increased risk for hip fracture.
Ann Intern Med.
1998;129:770-778.
Chao D, Espeland MA, Farmer D, et al. Effect of voluntary weight loss on bone mineral density in older overweight women.
J Am Geriatr Soc.
2000;48:753-759.
Reid IR. The roles of calcium and vitamin D in the prevention of osteoporosis.
Endocrinol Metab Clin North Am.
1998;27:389-398.
Cumming RG. Calcium intake and bone mass: a quantitative review of the evidence.
Calcif Tissue Int.
1990;47:194-201.
Dawson-Hughes B, Dallal GE, Krall EA, et al. A controlled trial of the effect of calcium supplementation on bone density in postmenopausal women.
N Engl J Med.
1990;323:878-883.
Peacock M, Liu G, Carey M, et al. Effect of calcium or 25OH vitamin D
3
dietary supplementation on bone loss at the hip in men and women over the age of 60.
J Clin Endocrinol Metab.
2000;85:3011-3019.
Prince RL. Diet and the prevention of osteoporotic fractures.
N Engl J Med.
1997;337:701-702.
Buckley LM, Leib ES, Cartularo KS, et al. Calcium and vitamin D
3
supplementation prevents bone loss in the spine secondary to low-dose corticosteroids in patients with rheumatoid arthritis. A randomized, double-blind, placebo-controlled trial.
Ann Intern Med.
1996;125:961-968.
Homik J, Suarez-Almazor ME, Shea B, et al. Calcium and vitamin D for corticosteroid-induced osteoporosis.
Cochrane Database Syst Rev.
2000;:CD000952.
Dawson-Hughes B, Harris SS, Krall EA, et al. Effect of withdrawal of calcium and vitamin D supplements on bone mass in elderly men and women.
Am J Clin Nutr.
2000;72:745-750.
Saltman PD, Strause LG. The role of trace minerals in osteoporosis.
J Am Coll Nutr.
1993;12:384-389.
Strause L, Saltman P, Smith KT, et al. Spinal bone loss in postmenopausal women supplemented with calcium and trace minerals.
J Nutr.
1994;124:1060-1064.
Kruger MC, Coetzer H, de Winter R, et al. Calcium, gamma-linolenic acid and eicosapentaenoic acid supplementation in senile osteoporosis.
Aging (Milano).
1998;10:385-394.
Bassey EJ, Littlewood JJ, Rothwell MC, et al. Lack of effect of supplementation with essential fatty acids on bone mineral density in healthy pre- and postmenopausal women: two randomized controlled trials of Efacal® v. calcium alone.
Br J Nutr.
2000;83:629-635.
Agnusdei D, Crepaldi G, Isaia G, et al. A double blind, placebo-controlled trial of ipriflavone for prevention of postmenopausal spinal bone loss.
Calcif Tissue Int.
1997;61:142-147.
Gennari C, Adami S, Agnusdei D, et al. Effect of chronic treatment with ipriflavone in postmenopausal women with low bone mass.
Calcif Tissue Int.
1997;61(suppl 1):S19-S22.
Valente M, Bufalino L, Castiglione GN, et al. Effects of 1-year treatment with ipriflavone on bone in postmenopausal women with low bone mass.
Calcif Tissue Int.
1994;54:377-380.
Kovacs AB. Efficacy of ipriflavone in the prevention and treatment of postmenopausal osteoporosis.
Agents Actions.
1994;41:86-87.
Adami S, Bufalino L, Cervetti R, et al. Ipriflavone prevents radial bone loss in postmenopausal women with low bone mass over 2 years.
Osteoporos Int.
1997;7:119-125.
Agnusdei D, Bufalino L, et al. Efficacy of ipriflavone in established osteoporosis and long-term safety.
Calcif Tissue Int.
1997;61(suppl 1):S23-S27.
Agnusdei D, Zacchei F, Bigazzi S, et al. Metabolic and clinical effects of ipriflavone in established post-menopausal osteoporosis.
Drugs Exp Clin Res.
1989;15:97-104.
Maugeri D, Panebianco P, Russo MS, et al. Ipriflavone-treatment of senile osteoporosis: results of a multicenter, double-blind clinical trial of 2 years.
Arch Gerontol Geriatr.
1994;19:253-263.
Passeri M, Biondi M, Costi D, et al. Effects of 2-year therapy with ipriflavone in elderly women with established osteoporosis.
Ital J Mineral Electrolyte Metab.
1995;9:137-144.
Agnusdei D, Adami S, Cervetti R, et al. Effects of ipriflavone on bone mass and calcium metabolism in postmenopausal osteoporosis.
Bone Miner.
1992;19(suppl 1):S43-S48.
Alexandersen P, Toussaint A, Christiansen C, et al. Ipriflavone in the treatment of postmenopausal osteoporosis: a randomized controlled trial.
JAMA.
2001;285:1482-1488.
Melis GB, Paoletti AM, Cagnacci A. Ipriflavone prevents bone loss in postmenopausal women.
Menopause.
1996;3:27-32.
Agnusdei D, Crepaldi G, Isaia G, et al. A double blind, placebo-controlled trial of ipriflavone for prevention of postmenopausal spinal bone loss.
Calcif Tissue Int.
1997;61:142-147.
Alexandersen P, Toussaint A, Christiansen C, et al. Ipriflavone in the treatment of postmenopausal osteoporosis: a randomized controlled trial.
JAMA.
2001;285:1482-1488.
Gambacciani M, Cappagli B, Piaggesi L, et al. Ipriflavone prevents the loss of bone mass in pharmacological menopause produced by GnRH-agonists.
Calcif Tissue Int.
1997;61(suppl 1):S15-S18.
Yamazaki I, Shino A, Shimizu Y, et al. Effect of ipriflavone on glucocorticoid-induced osteoporosis in rats.
Life Sci.
1986;38:951-958.
Gambacciani M, Spinetti A, Piaggesi L, et al. Ipriflavone prevents the bone mass reduction in premenopausal women treated with gonadotropin hormone-releasing hormone agonists.
Bone Miner.
1994;26:19-26.
Melis GB, Paoletti AM, Bartolini R, et al. Ipriflavone and low doses of estrogens in the prevention of bone mineral loss in climacterium.
Bone Miner.
1992;19(suppl 1):S49-S56.
Nozaki M, Hashimoto K, Inoue Y, et al. Treatment of bone loss in oophorectomized women with a combination of ipriflavone and conjugated equine estrogen.
Int J Gynaecol Obstet.
1998;62:69-75.
Maugeri D, Panebianco P, Russo MS, et al. Ipriflavone-treatment of senile osteoporosis: results of a multicenter double-blind clinical trial of 2 years.
Arch Gerontol Geriatr.
1994;19:253-263.
Moscarini M, Patacchiola F, Spacca G, et al. New perspectives in the treatment of postmenopausal osteoporosis: ipriflavone.
Gynecol Endocrinol.
1994;8:203-207.
Scali G, Mansanti P, Zurlo A, et al. Analgesic effect of ipriflavone versus sCalcitonin in the treatment of osteoporotic vertebral pain.
Curr Ther Res.
1991;49:1004-1010.
Potter SM, Baum JA, Teng H, et al. Soy protein and isoflavones: their effects on blood lipids and bone density in postmenopausal women.
Am J Clin Nutr.
1998;68(6
suppl):1375S-1379S.
Alekel DL, St. Germain A, Peterson CT, et al. Isoflavone-rich soy protein isolate attenuates bone loss in the lumbar spine of perimenopausal women.
Am J Clin Nutr.
2000;72:844-852.
Harrison E, Adjei A, Ameho C, et al. The effect of soybean protein on bone loss in a rat model of postmenopausal osteoporosis.
J Nutr Sci Vitaminol (Tokyo).
1998;44:257-268.
Fanti O, Faugere MC, Gang Z, et al. Systematic administration of genistein partially prevents bone loss in ovariectomized rats in a nonestrogen-like mechanism [abstract].
Am J Clin Nutr.
1998;68(suppl):1517S-1518S.
Arjmandi BH, Alekel L, Hollis BW, et al. Dietary soybean protein prevents bone loss in an ovariectomized rat model of osteoporosis.
J Nutr.
1996;126:161-167.
Fanti P, Monier-Faugere MC, Geng Z, et al. The phytoestrogen genistein reduces bone loss in short-term ovariectomized rats.
Osteoporos Int.
1998;8:274-281.
Anderson JJ, Ambrose WW, Garner SC. Biphasic effects of genistein on bone tissue in the ovariectomized, lactating rat model.
Proc Soc Exp Biol Med.
1998;217:345-350.
Malochet S, Picherit C, Horcajada-Molteni MN, et al. Do endurance training and soy isoflavones exhibit additive effects on ovariectomy-induced osteopenia in the rat? [abstract].
J Bone Miner Res.
1999;14(suppl 1):S536.
Arjmandi BH, Birnbaum R, Goyal NV, et al. Bone-sparing effect of soy protein in ovarian hormone-deficient rats is related to its isoflavone content.
Am J Clin Nutr.
1998;68(suppl):1364S-1368S.
Lees CJ, Ginn TA. Soy protein isolate diet does not prevent increased cortical bone turnover in ovariectomized macaques.
Calcif Tissue Int.
1998;62:557-558.
Jayo MJ. Dietary soy isoflavones and bone loss: a study in ovariectomized monkeys [abstract].
J Bone Miner Res.
1996;11(suppl 1):S228.
Gallagher JC, Rafferty K, Haynatzka V, et al. The effect of soy protein on bone metabolism [abstract].
J Nutr.
2000;130:666S-669S.
Fanti O, Faugere MC, Gang Z, et al. Systematic administration of genistein partially prevents bone loss in ovariectomized rats in a nonestrogen-like mechanism [abstract].
Am J Clin Nutr.
1998;68(suppl):1517S-1518S.
Fanti P, Monier-Faugere MC, Geng Z, et al. The phytoestrogen genistein reduces bone loss in short-term ovariectomized rats.
Osteoporos Int.
1998;8:274-281.
Feskanich D, Weber P, Willett WC, et al. Vitamin K intake and hip fractures in women: a prospective study.
Am J Clin Nutr.
1999;69:74-79.
Kanai T, Takagi T, Masuhiro K, et al. Serum vitamin K level and bone mineral density in post-menopausal women.
Int J Gynaecol Obstet.
1997;56:25-30.
Hart JP, Shearer MJ, Klenerman L, et al. Electrochemical detection of depressed circulating levels of vitamin K1 in osteoporosis.
J Clin Endocrinol Metab.
1985;60:1268-1269.
Bitensky L, Hart JP, Catterall A, et al. Circulating vitamin K levels in patients with fractures.
J Bone Joint Surg.
1988;70-B:663-664.
Hodges SJ, Pilkington MJ, Stamp TC, et al. Depressed levels of circulating menaquinones in patients with osteoporotic fractures of the spine and femoral neck.
Bone.
1991;12:387-389.
Jie KS, Gijsbers BL, Knapen MH, et al. Effects of vitamin K and oral anticoagulants on urinary calcium excretion.
Br J Haematol.
1993;83:100-104.
Knapen MH, Hamulyak K, Vermeer C. The effect of vitamin K supplementation on circulating osteocalcin (bone Gla protein) and urinary calcium excretion.
Ann Intern Med.
1989;111:1001-1005.
Tomita A, Fujita T, Takatsuki K, et al. 47 Ca kinetic study and vitamin K 2 in postmenopausal osteoporosis [in Japanese].
Horumon To Rinsho.
1971;19:731-736.
Orimo H, Shiraki M, Fujita T, et al. Clinical evaluation of menatetrenone in the treatment of involutional osteoporosis—a double-blind multicenter comparative study with 1 alpha-hydroxy vitamin D3 [abstract].
J Bone Miner Res.
1992;7(suppl 1):S122.
Booth SL, Tucker KL, Chen H, et al. Dietary vitamin K intakes are associated with hip fracture but not with bone mineral density in elderly men and women.
Am J Clin Nutr.
2000;71:1201-1208.
Baulieu EE, Thomas G, Legrain S, et al. Dehydroepiandrosterone (DHEA), DHEA sulfate, and aging: contribution of the DHEAge Study to a sociobiomedical issue.
Proc Natl Acad Sci USA.
2000;97:4279-4284.
Labrie F, Diamond P, Cusan L, et al. Effect of 12-month dehydroepiandrosterone replacement therapy on bone, vagina and endometrium in postmenopausal women.
J Clin Endocrinol Metab.
1997;82:3498-3505.
van Vollenhoven RF, Park JL, Genovese MC, et al. A double-blind, placebo-controlled, clinical trial of dehydroepiandrosterone in severe systemic lupus erythematosus.
Lupus.
1999;8:181-187.
Greendale GA, Edelstein S, Barrett-Connor E. Endogenous sex steroids and bone mineral density in older women and men: the Rancho Bernardo Study.
J Bone Miner Res.
1997;12:1833-1843.
Hegarty V, May H, Khaw K. Tea drinking and bone mineral density in older women.
Am J Clin Nutr.
2000;71:1003-1007.
Nielsen FH, Hunt CD, Mullen LM, et al. Effect of dietary boron on mineral, estrogen and testosterone metabolism in postmenopausal women.
FASEB J.
1987;1:394-397.
Naghii MR, Samman S. The effect of boron supplementation on its urinary excretion and selected cardiovascular risk factors in healthy male subjects.
Biol Trace Elem Res.
1997;56:273-286.
Nielsen FH, Hunt CD, Mullen LM, et al. Effect of dietary boron on mineral, estrogen and testosterone metabolism in postmenopausal women.
FASEB J.
1987;1:394-397.
Munger RG, Cerhan JR, Chiu BC. Prospective study of dietary protein intake and risk of hip fracture in postmenopausal women.
Am J Clin Nutr.
1999;69:147-152.
Schurch MA, Rizzoli R, Slosman D, et al. Protein supplements increase serum insulin-like growth factor-I levels and attenuate proximal femur bone loss in patients with recent hip fracture. A randomized, double-blind, placebo-controlled trial.
Ann Intern Med.
1998;128:801-809.
Prior JC. Progesterone as a bone-trophic hormone.
Endocr Rev.
1990;11:386-398.
Verhaar HJ, Damen CA, Duursma SA, et al. A comparison of the action of progestins and estrogen on the growth and differentiation of normal adult human osteoblast-like cells in vitro.
Bone.
1994;15:307-311.
Lee JR. Is natural progesterone the missing link in osteoporosis prevention and treatment?
Med Hypotheses.
1991;35:316-318.
Lee JR. Osteoporosis reversal with transdermal progesterone.
Lancet.
1990;336:1327.
Lee JR. Osteoporosis reversal, the role of progesterone.
Int Clin Nutr Rev.
1990;10:384-391.
Leonetti
HB, Longo S, Anasti JN. Transdermal progesterone cream for vasomotor symptoms and postmenopausal bone loss.
Obstet Gynecol.
1999;94:225-228.
Writing Group for the PEPI Trial. Effects of hormone replacement therapy on endometrial histology in postmenopausal women: the postmenopausal estrogen/progestin interventions (PEPI) trial.
JAMA.
1996;275:370-375.
Minaguchi H, Uemura T, Shirasu K, et al. Effect of estriol on bone loss in postmenopausal Japanese women: a multicenter prospective open study.
J Obstet Gynaecol Res.
1996;22:259-265.
Itoi H, Minakami H, Sato I. Comparison of the long-term effects of oral estriol with the effects of conjugated estrogen, 1-alpha-hydroxyvitamin D3 and calcium lactate on vertebral bone loss in early menopausal women.
Maturitas.
1997;28:11-17.
Hayashi T, Ito I, Kano H, et al. Estriol (E3) replacement improves endothelial function and bone mineral density in very elderly women.
J Gerontol A Biol Sci Med Sci.
2000;55:B183-B190.
Holland EF, Leather AT, Studd JW. Increase in bone mass of older postmenopausal women with low mineral bone density after one year of percutaneous oestradiol implants.
Br J Obstet Gynaecol.
1995;102:238-242.
Nozaki M, Hashimoto K, Inoue Y, et al. Usefulness of estriol for the treatment of bone loss in postmenopausal women [in Japanese; English abstract].
Nippon Sanka Fujinka Gakkai Zasshi.
1996;48:83-88.
Lindsay R, Hart DM, Maclean A, et al. Bone loss during oestriol therapy in postmenopausal women.
Maturitas.
1979;1:279-285.
Granberg S, Ylostalo P, Wikland M, et al. Endometrial sonographic and histologic findings in women with and without hormonal replacement therapy suffering from postmenopausal bleeding.
Maturitas.
1997;27:35-40.
Weiderpass E, Baron JA, Adami HO, et al. Low-potency oestrogen and risk of endometrial cancer: a case-control study.
Lancet.
1999;353:1824-1828.
Montoneri C, Zarbo G, Garofalo A, et al. Effects of estriol administration on human postmenopausal endometrium.
Clin Exp Obstet Gynecol.
1987;14:178-181.
Takahashi K, Manabe A, Okada M, et al. Efficacy and safety of oral estriol for managing postmenopausal symptoms.
Maturitas.
2000;34:169-177.
Lippman M, Monaco ME, Bolan G. Effects of estrone, estradiol and estriol on hormone-responsive human breast cancer in long-term tissue culture.
Cancer Res.
1977;37:1901-1907.
Cashman KD, Baker A, Ginty F, et al. No effect of copper supplementation on biochemical markers of bone metabolism in healthy young adult females despite apparently improved copper status.
Eur J Clin Nutr.
2001;55:525-531.
Dawson-Hughes B, Harris S. Calcium intake influences the association of protein intake with rates of bone loss in elderly men and women.
Am J Clin Nutr.
2002;75:773-779.
Kahn AJ, Haloran B. Dehydroepiandrosterone supplementation and bone turnover in middle-aged to elderly men.
J Clin Endocrinol Metab.
2002;87:1544-1549.
Wuttke W. Abstracts P3-333, P3-317. 84th annual meeting of The Endocrine Society; June 21, 2002.
Pfeifer M, Begerow B, Minne H, et al. Effects of a short-term vitamin D and calcium supplementation on body sway and secondary hyperparathyroidism in elderly women.
J Bone Miner Res.
2000;15:1113-1118.
Janssen HC, Samson MM, Verhaar HJ. Vitamin D deficiency, muscle function, and falls in elderly people.
Am J Clin Nutr.
2002;75:611-615.
Messina M, Gardner C, Barnes S. Gaining insight into the health effects of soy but a long way still to go: commentary on the fourth International Symposium on the Role of Soy in Preventing and Treating Chronic Disease.
J Nutr.
2002;132:547S.
Morabito N, Crisafulli A, Vergara C, et al. Effects of genistein and hormone-replacement therapy on bone loss in early postmenopausal women: a randomized double-blind, placebo-controlled study.
J Bone Miner Res.
2002;17:1904-1912.
Gordon CM, Grace E, Emans SJ. Effects of oral dehydroepiandrosterone on bone density in young women with anorexia nervosa: a randomized trial.
J Clin Endocrinol Metab.
2002;87:4935-4941.
Beattie JH, Peace HS. The influence of a low boron-diet and boron supplementation on bone, major mineral and sex steroid metabolism in postmenopausal women.
Br J Nutr.
1993;69:871-884.
Michaelsson K, Lithell H, Vessby B, et al. Serum retinol levels and the risk of fracture.
N Engl J Med.
2003;348:287-294.
Trivedi DP, Doll R, Khaw KT. Effect of four monthly oral vitamin D3 (cholecalciferol) supplementation on fractures and mortality in men and women living in the community: randomised double blind controlled trial.
BMJ.
2003;326:469.
Braam LA, Knapen MH, Geusens P, et al. Vitamin K1 supplementation retards bone loss in postmenopausal women between 50 and 60 years of age.
Calcif Tissue Int.
2003;73:21-26.
Bischoff HA, Stahelin HB, Dick W, et al. Effects of vitamin D and calcium supplementation on falls: a randomized controlled trial.
J Bone Miner Res.
2003;18:343-351.
Latham NK, Anderson CS, Lee A, et al. A randomized, controlled trial of quadriceps resistance exercise and vitamin D in frail older people: the frailty interventions trial in elderly subjects (FITNESS).
J Am Geriatr Soc.
2003;51:291-299.
Jones G, Dwyer T, Hynes K, et al. A randomized controlled trial of phytoestrogen supplementation, growth and bone turnover in adolescent males.
Eur J Clin Nutr.
2003;57:324-327.
Reginster JY, Meunier PJ. Strontium ranelate phase 2 dose-ranging studies: PREVOS and STRATOS studies.
Osteoporos Int.
2003;14(suppl 3):S56-65. Epub 2003 Mar 12.
Marie PJ. Optimizing bone metabolism in osteoporosis: insight into the pharmacologic profile of strontium ranelate.
Osteoporos Int.
2003;14:9-12.
Boivin G, Meunier PJ. The mineralization of bone tissue: a forgotten dimension in osteoporosis research.
Osteoporos Int.
2003;14(suppl 3):19-24.
Skov A, Haulrik N, Toubro S, et al. Effect of protein intake on bone mineralization during weight loss: a 6-month trial.
Obes Res.
2002;10:432-438.
Promislow J, Goodman-Gruen D, Slymen D, et al., Protein consumption and bone mineral density in the elderly: the Rancho Bernardo study.
Am J Epidemiol.
2002;155:636-644.
Latham NK, Anderson CS, Reid IR. Effects of vitamin D supplementation on strength, physical performance, and falls in older persons: a systematic review.
J Am Geriatr Soc.
2003;51:1219-1226.
Shea B, Wells G, Cranney A, et al. Calcium supplementation on bone loss in postmenopausal women.
Cochrane Database Syst Rev.
2003;4:CD004526.
Harwood RH, Sahota O, Gaynor K, et al. A randomised, controlled comparison of different calcium and vitamin D supplementation regimens in elderly women after hip fracture: The Nottingham Neck of Femur (NONOF) Study.
Age Ageing.
2004;33:45-51.
Kenny AM, Biskup B, Robbins B, et al. Effects of vitamin D supplementation on strength, physical function, and health perception in older, community-dwelling men.
J Am Geriatr Soc.
2003;51:1762-1767.
Cotter A, Cashman KD. Genistein appears to prevent early postmenopausal bone loss as effectively as hormone replacement therapy.
Nutr Rev.
2003;61:346-351.
Chen YM, Ho SC, Lam SS, et al. Soy isoflavones have a favorable effect on bone loss in Chinese postmenopausal women with lower bone mass: a double-blind, randomized, controlled trial.
J Clin Endocrinol Metab.
2003;88:4740-4747.
Atkinson C, Compston JE, Day NE, et al. The effects of phytoestrogen isoflavones on bone density in women: a double-blind, randomized, placebo-controlled trial.
Am J Clin Nutr.
2004;79:326-333.
Yoles I, Yogev Y, Frenkel Y, et al. Tofupill/Femarelle (DT56a): a new phyto-selective estrogen receptor modulator-like substance for the treatment of postmenopausal bone loss.
Menopause.
2003;10:522-525.
Meunier PJ, Roux C, Seeman E, et al. The effects of strontium ranelate on the risk of vertebral fracture in women with postmenopausal osteoporosis.
N Engl J Med.
2004;350:459-468.
Fontana L, Shew JL, Holloszy JO, Villareal DT. Low bone mass in subjects on a long-term raw vegetarian diet.
Arch Intern Med.
2005;165:684-689.
Porthouse J, Cockayne S, King C, et al. Randomised controlled trial of calcium and supplementation with cholecalciferol (vitamin D3) for prevention of fractures in primary care.
BMJ.
2005;330:1003.
Avenell A, Campbell MK, et al. Oral vitamin D3 and calcium for secondary prevention of low-trauma fractures in elderly people: a randomised placebo-controlled trial.
Lancet.
2005;365:1621-1628.
Matkovic V, Goel PK, Badenhop-Stevens NE, et al. Calcium supplementation and bone mineral density in females from childhood to young adulthood: a randomized controlled trial.
Am J Clin Nutr.
2005;81:175-188.
Dodiuk-Gad RP, Rozen GS, Rennert G, et al. Sustained effect of short-term calcium supplementation on bone mass in adolescent girls with low calcium intake.
Am J Clin Nutr.
2005;81:168-174.
Lloyd T, Andon MB, Rollings N, et al. Calcium supplementation and bone mineral density in adolescent girls.
JAMA.
1993;270:841-844.
Barr SI, Petit MA, Vigna YM, et al. Eating attitudes and habitual calcium intake in peripubertal girls are associated with initial bone mineral content and its change over 2 years.
J Bone Miner Res.
2001;16:940-947.
Lanou AJ, Berkow SE, Barnard ND, et al. Calcium, dairy products, and bone health in children and young adults: a reevaluation of the evidence.
Pediatrics.
2005;115:736-743.
Delmas PD. Clinical effects of strontium ranelate in women with postmenopausal osteoporosis.
Osteoporos Int.
2004 Dec 2. [Epub ahead of print]
Reginster JY, Seeman E, DE Vernejoul MC, et al. Strontium ranelate reduces the risk of nonvertabral fractures in post-menopausal women with osteoporosis: tropos study.
J Clin Endocrinol Metab.
2005 Feb 22. [Epub ahead of print]
Baecker N, Boese A, Schoenau E, et al. L-Arginine, the natural precursor of NO, is not effective for preventing bone Loss in postmenopausal women.
J Bone Miner Res.
2005;20:471-479.
Prince RL, Devine A, Dhaliwal SS, et al. Effects of calcium supplementation on clinical fracture and bone structure: results of a 5-year, double-blind, placebo-controlled trial in elderly women.
Arch Intern Med.
2006;166:869-875.
Daly RM, Bass S, Nowson C. Long-term effects of calcium-vitamin-D(3)-fortified milk on bone geometry and strength in older men.
Bone.
2006 May 23. [Epub ahead of print].
Barger-Lux MJ, Davies KM, Heaney RP, et al. Calcium supplementation does not augment bone gain in young women consuming diets moderately low in calcium.
J Nutr.
2005;135:2362-2366.
French SA, Story M, Fulkerson JA, et al. Increasing weight-bearing physical activity and calcium-rich foods to promote bone mass gains among 9-11 year old girls: outcomes of the Cal-Girls study.
Int J Behav Nutr Phys Act.
2005 Jul 19. [Epub ahead of print].
Cheng S, Lyytikainen A, Kroger H, et al. Effects of calcium, dairy product, and vitamin D supplementation on bone mass accrual and body composition in 10-12-y-old girls: a 2-y randomized trial.
Am J Clin Nutr.
2005;82:1115-1126.
Courteix D, Jaffre C, Lespessailles E, et al. Cumulative effects of calcium supplementation and physical activity on bone accretion in premenarchal children: a double-blind randomised placebo-controlled trial.
Int J Sports Med.
2005;26:332-338.
Bischoff-Ferrari HA, Conzelmann M, Stahelin HB, et al. Is fall prevention by vitamin D mediated by a change in postural or dynamic balance?
Osteoporos Int.
2006 Mar 1. [Epub ahead of print]
Bischoff-Ferrari HA, Orav EJ, Dawson-Hughes B, et al. Effect of cholecalciferol plus calcium on falling in ambulatory older men and women: a 3-year randomized controlled trial.
Arch Intern Med.
2006;166:424-430.
Sato Y, Iwamoto J, Kanoko T, et al. Low-dose vitamin D prevents muscular atrophy and reduces falls and hip fractures in women after stroke: a randomized controlled trial.
Cerebrovasc Dis.
2005 Jul 27. [Epub ahead of print]
Law M, Withers H, Morris J, et al. Vitamin D supplementation and the prevention of fractures and falls: results of a randomised trial in elderly people in residential accommodation.
Age Ageing.
2006 Apr 26. [Epub ahead of print]
Huang HY, Yang HP, Yang HT, et al. One-year soy isoflavone supplementation prevents early postmenopausal bone loss but without a dose-dependent effect.
J Nutr Biochem.
2006 Feb 3. [Epub ahead of print].
Ye YB, Tang XY, Verbruggen MA, et al. Soy isoflavones attenuate bone loss in early postmenopausal Chinese women: A single-blind randomized, placebo-controlled trial.
Eur J Nutr.
2006 Jun 8. [Epub ahead of print]
Wu J, Oka J, Higuchi M, et al. Cooperative effects of isoflavones and exercise on bone and lipid metabolism in postmenopausal Japanese women: a randomized placebo-controlled trial.
Metabolism.
2006;55:423-433.
Marie PJ. Strontium ranelate: a dual mode of action rebalancing bone turnover in favour of bone formation.
Curr Opin Rheumatol.
2006;18(suppl 1):S11-S15.
Purwosunu Y, Rachman IA, Reksoprodjo S, et al. Vitamin K treatment for postmenopausal osteoporosis in Indonesia.
J Obstet Gynaecol Res.
2006;32:230-234.
Martini LA, Booth SL, Saltzman E, et al. Dietary phylloquinone depletion and repletion in postmenopausal women: effects on bone and mineral metabolism.
Osteoporos Int.
2006 Mar 18. [Epub ahead of print]
Purwosunu Y, Rachman IA, Reksoprodjo S, et al. Vitamin K treatment for postmenopausal osteoporosis in Indonesia.
J Obstet Gynaecol Res.
2006;32:230-234.
Sato Y, Honda Y, Iwamoto J, et al. Homocysteine as a predictive factor for hip fracture in stroke patients.
Bone.
2005;36:721-726.
Sato Y, Iwamoto J, Kanoko T, et al. Homocysteine as a predictive factor for hip fracture in elderly women with Parkinson's disease.
Am J Med.
2005;118:1250-1255.
McLean RR, Jacques PF, Selhub J, et al. Homocysteine as a predictive factor for hip fracture in older persons.
N Engl J Med.
2004;350:2042-2049.
Sato Y, Honda Y, Iwamoto J, et al. Effect of folate and mecobalamin on hip fractures in patients with stroke: a randomized controlled trial.
JAMA.
2005;293:1082-1088.
Jankowski CM, Gozansky WS, Schwartz RS, et al. Effects of DHEA replacement therapy on bone mineral density in older adults: a randomized, controlled trial.
J Clin Endocrinol Metab.
2006 May 30. [Epub ahead of print]
Spector T, Calomme M, Anderson S, et al. Effect on bone turnover and BMD of low dose oral silicon as an adjunct to calcium/vitamin D3 in a randomized, placebo-controlled trial. Poster presented at: ASBMR 27th Annual Meeting; September 2005; Nashville, TN.
Bunout D, Barrera G, Leiva , et al. Effects of vitamin D supplementation and exercise training on physical performance in Chilean vitamin D deficient elderly subjects.
Exp Gerontol.
2006 Jun 21. [Epub ahead of print]
Heaney RP. Advances in therapy for osteoporosis.
Clin Med Res.
2003;1:93-99.
Reid IR, Mason B, Horne A, et al. Randomized controlled trial of calcium in healthy older women.
Am J Med.
2006;119:777-785.
Carpenter TO, Delucia MC, Zhang JH, et al. A randomized controlled study of effects of dietary magnesium oxide supplementation on bone mineral content in healthy girls.
J Clin Endocrinol Metab.
2006 Oct 3. [Epub ahead of print]
Kelley GA, Kelley KS. Exercise and bone mineral density at the femoral neck in postmenopausal women: a meta-analysis of controlled clinical trials with individual patient data.
Am J Obstet Gynecol.
2006;194:760-767.
Martyn-St James M, Carroll S. High-intensity resistance training and postmenopausal bone loss: a meta-analysis.
Osteoporos Int.
2006;17:1225-1240.
Kelley GA, Kelley KS, Tran ZV. Exercise and bone mineral density in men: a meta-analysis.
J Appl Physiol.
2000;88:1730-1736.
Bonaiuti D, Shea B, Iovine R, et al. Exercise for preventing and treating osteoporosis in postmenopausal women.
Cochrane Database Syst Rev.
2002;(3):CD000333.
Bolton-Smith C, McMurdo ME, Paterson CR, et al. A two-year randomized controlled trial of vitamin K(1) (phylloquinone) and vitamin D(3) Plus calcium on the bone health of older women.
J Bone Miner Res.
2007 Jan 23. [Epub ahead of print]
Green TJ, McMahon JA, Skeaff CM, et al. Lowering homocysteine with B vitamins has no effect on biomarkers of bone turnover in older persons: a 2-y randomized controlled trial.
Am J Clin Nutr.
2007;85:460-464.
Knapen MH, Schurgers LJ, Vermeer C. Vitamin K(2) supplementation improves hip bone geometry and bone strength indices in postmenopausal women.
Osteoporos Int.
2007 Feb 8. [Epub ahead of print]
Cockayne S, Adamson J, Lanham-New S, et al. Vitamin K and the prevention of fractures: systematic review and meta-analysis of randomized controlled trials.
Arch Intern Med.
2006;166:1256-1261.
Ting GP, Tan SY, Chan SP, et al. A follow-up study on the effects of a milk supplement on bone mineral density of postmenopausal Chinese women in Malaysia.
J Nutr Health Aging.
2007;11:69-73.
Chee WS, Suriah AR, Chan SP. The effect of milk supplementation on bone mineral density in postmenopausal Chinese women in Malaysia.
Osteoporos Int.
2003;14:828-34. [Epub 2003 Aug 12]
Woo J, Hong A, Lau E, et al. A randomised controlled trial of Tai Chi and resistance exercise on bone health, muscle strength, and balance in community-living elderly people.
Age Ageing.
2007 Mar 13. [Epub ahead of print]
Ma DF, Qin LQ, Wang PY, et al. Soy isoflavone intake inhibits bone resorption and stimulates bone formation in menopausal women: meta-analysis of randomized controlled trials.
Eur J Clin Nutr.
2007 Mar 28. [Epub ahead of print]
Zhang G, Qin L, Shi Y. Epimedium-derived phytoestrogen flavonoids exert beneficial effect on preventing bone loss in late postmenopausal women: a 24-month randomized, double-blind and placebo-controlled trial.
J Bone Miner Res.
2007 Apr 9. [Epub ahead of print]
Wayne PM, Kiel DP, Krebs DE, et al. The effects of tai chi on bone mineral density in postmenopausal women: a systematic review.
Arch Phys Med Rehabil.
2007;88:673-680.
Bischoff-Ferrari HA, Dawson-Hughes B. Where do we stand on vitamin D?
Bone.
2007 Mar 24. [Epub ahead of print]
Lyons RA, Johansen A, Brophy S, et al. Preventing fractures among older people living in institutional care: a pragmatic randomised double blind placebo controlled trial of vitamin D supplementation.
Osteoporos Int.
2007;18:811-818.
Wu J, Oka J, Ezaki J, et al. Possible role of equol status in the effects of isoflavone on bone and fat mass in postmenopausal Japanese women: a double-blind, randomized, controlled trial.
Menopause.
2007 Apr 25. [Epub ahead of print]
Krapf R. Partial neutralization of the acidogenic Western diet with potassium citrate increases bone mass in postmenopausal women with osteopenia.
Int J Prosthodont.
2007;20:113-114.
Marini H, Minutoli L, Polito F, et al. Effects of the phytoestrogen genistein on bone metabolism in osteopenic postmenopausal women.
Ann Intern Med.
2007;146:839-847.
Narita Y, Nomura J, Ohta S, et al. Royal jelly stimulates bone formation: physiologic and nutrigenomic studies with mice and cell lines.
Biosci Biotechnol Biochem.
2006;70:2508-2514.
Demos LL, Kazda H, Cicuttini FM, et al. Water fluoridation, osteoporosis, fractures—recent developments.
Aust Dent J.
2001;46:80-87.
Herrmann M, Umanskaya N, Traber L, et al. The effect of B-vitamins on biochemical bone turnover markers and bone mineral density in osteoporotic patients: a 1-year double blind placebo controlled trial.
Clin Chem Lab Med.
2007 Nov 18. [Epub ahead of print]
von Muhlen D, Laughlin GA, Kritz-Silverstein D, et al. Effect of dehydroepiandrosterone supplementation on bone mineral density, bone markers, and body composition in older adults: the DAWN trial.
Osteoporos Int.
2007 Dec 15.
Bolland MJ, Barber PA, Doughty RN, et al. Vascular events in healthy older women receiving calcium supplementation: randomised controlled trial.
BMJ.
2008 Jan 15.
Booth SL, Dallal G, Shea MK, et al. Effect of vitamin K Supplementation on bone loss in elderly men and women.
J Clin Endocrinol Metab.
2008 Feb 5.
Brink E, Coxam V, Robins S, et al. Long-term consumption of isoflavone-enriched foods does not affect bone mineral density, bone metabolism, or hormonal status in early postmenopausal women: a randomized, double-blind, placebo controlled study.
Am J Clin Nutr.
2008;87:761-770.
Salovaara K, Tuppurainen M, Kärkkäinen M, et al. Effect of vitamin D3 and calcium on fracture risk in 65- to 71-year old women - a population-based 3-year randomized controlled trial: OSTPRE-FPS study.
J Bone Miner Res.
2010 Jan 29 early online.
Warensjö E, Byberg L, Melhus H, et al. Dietary calcium intake and risk of fracture and osteoporosis: prospective longitudinal cohort study.
BMJ.
2011;342:d1473.
Wayne PM, Kiel DP, Buring JE, et al. Impact of Tai Chi exercise on multiple fracture-related risk factors in post-menopausal osteopenic women: a pilot pragmatic, randomized trial.
BMC Complement Altern Med. 2012;12:7.
Last reviewed July 2012 by EBSCO CAM Review Board
Please be aware that this information is provided to supplement the care provided by your physician. It is neither intended nor implied to be a substitute for professional medical advice. CALL YOUR HEALTHCARE PROVIDER IMMEDIATELY IF YOU THINK YOU MAY HAVE A MEDICAL EMERGENCY. Always seek the advice of your physician or other qualified health provider prior to starting any new treatment or with any questions you may have regarding a medical condition.
Copyright © EBSCO Publishing. All rights reserved.